Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is a prescription drug used to treat COPD. With COPD, you have lung damage that worsens over time ...

Shayna Chamberlin's monthly prescription went from $210 to $37. She credits GoodRx. "It saved me $300 this year alone," Chamberlin said. "I know how insane health care prices are as someone who ...

Full Year 2024 Adjusted EBITDA: Expected over $255 million, up about 18% from 2023. GoodRx Holdings Inc (NASDAQ:GDRX) reported a 6% year-over-year increase in total revenue for the second quarter ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Trelegy is a key drug for GSK, and analysts predict peak sales in excess of $1billion. The company needs new revenues in respiratory diseases, as its ageing blockbuster inhaler Advair will face ...